4Um SW, Lee SW, Kwon SY, et al. Low serum concentrations of anti - tuberculosis drugs and determinants of their serum levels[J] . Int J Tuberc Lung Dis, 2007,11(9) :972.
5Pooransingh S, Smith EG, Innes JA. Chest physicians' and microbiologists' awareness and demand for drug monitoring in the treatment of TB[J ]. Cornrnun Dis Public Health, 2003,6(4) : 317.
6Peloquin C. Use of therapeutic drug monitoring in tuberculosis patients[J ]. Chest, 2004,126(6) : 1 722.
7Ray J, Gardiner I, Marriott D. Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid[J]. Intern Med J, 2003, 33(5) : 229.
8Li J, Burzynski JN, Lee YA, et al. Use of therapeutic drug monitoring for multidrug - resistant tuberculosis patients[J ]. Chest ,2004, 126(6) : 1 770.
9Brennan-Benson P, Lyus R, Harrison T, et al. Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all[J ] .AIDS, 2005,19(14) : 1 541.
10Matteelli A, Regazzi M, Villani P,et al. Multiple - dose pharmacokinetics of efavirenz with and without the use of rifampiein in HIV-positive patients[J] . Curt HIV Res, 2007,5(3):349.
6ContelJR JE, Golden JA, McQuitty M, et al.Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid[J].Antimicrob Agents Chemother, 2002,46(8) :2 358.
7Ray J, Gardiner I, Marriott D.Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid[J]. Intern Med J, 2003,33(5) : 229.
8Bolt HM. Rifampicin, a keystone inducer of drug metabolism: from Herbert Remmer' s pioneering ideas to modem concepts[J]. Drug Metabolism Reviews, 2004, 36 (324) : 497.
9Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance[J].Clin Pharmacokinet, 2003,2 (9) : 819.
10Polasek TM, Elliot D J, Somogyi AA, et al. An evaluation of potential mechanism-based in activation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid[J].Br J Clin Pharmacol,2006,61(5) :570.
